Tag Archive for: Matthew Hayn

Posts

When Not to be a Doctor

Hayn.2015“Now you know. And knowing is half the battle.” As a child growing up in the 80’s, I heard this line at the end of every G.I. Joe cartoon show. But what if knowing doesn’t really help?

As a urologic oncologist, I (try) to know as much as possible about urology and urologic cancers. I counsel patients about their diagnosis, treatment, and prognosis. I give them facts and statistics, quote predictive nomograms, describe operations, draw pictures, and give them my expert opinion. I would like to think that I am being helpful.

But am I really helping? Do patients and family members really want all of that?

Twenty years ago, my mother-in-law had breast cancer. She had a lumpectomy, chemotherapy and radiation. She “cured” and went on with her life. Her cancer was mentioned occasionally, but only as a remote event. We mostly forgot about it.

Then, 4 years ago, she felt a lump next to her breast. Eventually it was biopsied – recurrent breast cancer. She saw the experts at my hospital. Bad news – the cancer had spread (in a big way) to her liver.

We were all devastated, especially my wife. After 10 years away, she had just moved back to New England. She was looking forward to spending more time with her mom and her family. Cancer had reared its ugly head, and turned that all upside down.

What did I do? I did what I thought would be helpful. Looked up treatment options. Looked up 5-year survival estimates. I gathered information. Lots of information. This turned out to be an unmitigated disaster. It did not help my wife. It made things worse.

In 2014, Paul Kalanithi, then a Neurosurgery resident at Stanford, wrote a great piece in the New York Times about his advanced lung cancer diagnosis.

His basic message – don’t obsess over the numbers. Live your life. Get on.

I had failed my wife in that moment by acting like “a doctor”. She didn’t want numbers or survival estimates. She wanted me to act like a husband and friend. She wanted sympathy, a hug, and a shoulder to cry on. She wanted me to acknowledge how much it sucked that her mom had cancer.

In the end, patients want both, and they need both. They need expert advice and “the numbers”. More importantly, they want and need compassion and empathy. Thankfully, my mother-in-law continues to do well to this day.

Communicating both of these effectively will make me a better doctor, a better husband, and a better person.

 

Dr Matt Hayn

Medical Direction, Genitourinary Cancer Program

Maine Medical Center

Portland, Maine

@matthayn

 

AUA Blog – Day 3 and 4 – Monday and Tuesday

The American Urological Association (AUA) 2013 national meeting remains in full swing in beautiful San Diego. Not sure what is going on with the weather (two days in a row of rain?), but plenty of great things going on inside the convention center.

The “main event” on Monday was Dr. Ballentine Carter’s presentation of the AUA’s new Guidelines on the Early Detection of Prostate Cancer . Dr. Carter spoke to a packed house (the Fire Marshall was turning people away!).

For those who missed the talk, the AUA added a second session on Tuesday. Further comments from the AUA can be found here. Whatever your opinion regarding the new guidelines, and there were many prominent urologists who voiced their concerns about the guidelines, urologists will need to be able to speak intelligently to patients and primary care physicians. In the same session, Dr. Michael Cookson gave the AUA Guideline presentation on castration resistant prostate cancer which seemed better received than the PSA Guidance which certainly got many urologists hot and bothered.

On Monday, the Young Urologists Forum focused on the business aspect of urology (something I heard very little about in training), with informative talks by Dr. Raju Thomas, Dr. Koushik Shaw and Dr. Neil Baum. Thanks to Dr. Mike Ost and the YU Committee for putting together a great program.

Speaking of young urologists, the Southeastern section took home first prize in the Second Annual Residents Bowl, besting the Western section in the finals on Monday.

Southeastern Section of AUA claim the honours in the Annual Residents Bowl

The Monday plenary session included discussions on the contemporary uses of neuromodulation and the management of iatrogenic ureteral injury. BJUI Editor-in-Chief Dr. Prokar Dasgupta, gave an informative lecture on the current applications of botulinum toxin in the lower urinary tract. Prostate cancer made it into the Endocrine Forum on Monday, with Dr. Scardino and Dr. Klotz debating the treatment of men with low risk prostate cancer. Jumping ahead, a similar debate was held during the Tuesday plenary between Dr. Carroll and Dr. Tewari with roles reversing somewhat as Dr Tewari argued the case for surveillance while Dr Carroll took us through some of the pitfalls.

Also on Monday, Dr. Vincent Laudone gave late-breaking news regarding the randomized trial between open and robotic radical cystectomy at MSKCC. Bottom line – no difference was found regarding oncologic or perioperative outcomes. In particular, the robotic approach did not reduce the complication rate which remained at about 60% in both arms. Cost difference, which seems to be on everyone’s mind, was not addressed. Other trials between open and robotic cystectomy remain ongoing and the jury appears out here.

Dr. Christopher Kane moderated a session debating the use of simulation in robotic surgery between Drs. Sundaram (pro) and Nadler (con). Dr. Kane concluded the debate by stating that basic robotic training is important but limited by cost and duty hour restrictions. In addition, further studies are needed to determine if virtual robotic training actually helps performance.

One of the more contentious areas of prostate cancer, HIFU and focal therapy, received much attention during various poster sessions this year. Abstract #553 reported five-year oncological outcomes following HIFU in the UK in over 500 patients. Disappointingly, 38% of men who had a biopsy had residual cancer. About one third of patients had androgen deprivation therapy upfront with a further 30% requiring salvage treatment. The authors described the disease-free outcomes as “reasonable”. Abstract #1356 from the same authors reported outcomes in 110 patients undergoing focal therapy using the same HIFU technology. Again, 38% of patients had a positive biopsy. Both of these papers provoked much reaction from the floor and across social media. These are experimental interventions which should only be undertaken in appropriate trials.

The aging US population (10,000 people turn 65 every day and will for the next 15 years) coupled with the average age of urologists (mid-50’s!) will create a serious manpower shortage over the next several years. As an illustration, abstract #153 reported that 14 counties in Oregon have zero urologists and men in those counties are more likely to get bladder cancer.

From Monday, abstract #1041 (awarded best poster for MP40), confirmed what habitual coffee drinkers already know – that high dosage coffee increases LUTS and urine volume compared to decaffeinated coffee or water. Dr. Tom Walsh and colleagues were awarded best poster (abstract #1241) for MP46 for evaluating a smartphone application to assess the penile deformity in men with Peyronie’s disease. Another best of session – Dr. Penson (@urogeek) and colleagues reported that men with prostate cancer today (CAESER) have more baseline dysfunction that men 20 years ago (PCOS) – abstract #449. There were many more great abstracts out there…too many to list in this blog.

The Urological Society of Australia and New Zealand hosted a great reception on Monday night. Several prominent uro-twitterati (including yours truly) and other urologic “heavy hitters” were in attendance.

Thanks to the Aussies and Kiwis for a wonderful event. Strangely, they were not serving Foster’s at the event.

Tuesday’s plenary included several sessions on the management of both low and high-risk prostate cancer. The main auditorium was absolutely packed for what was one of the best sessions of the week.

Dr Hein Van Poppel, Secretary-General Adjunct of the European Association of Urology (EAU), delivered an outstanding plenary on the management of high-risk localised prostate cancer. His clear message – surgery should always be considered first with radiotherapy and androgen deprivation therapy later if required – was very well received. Dr Ed Messing introduced a fantastic session on molecular markers in prostate cancer led by Dr’s Alan Partin, Dan Lin and Theo Van der Kwast. Key messages here were that the Phi test already has a role in clinical practice; PCA3/TEMPRSS2ERG fusion is emerging; and for sure, we will see genetic markers in clinical practice very soon. In fact the UCSF group generated a lot of media headlines on Tuesday evening when the commercialization of their genetic test was announced ahead of its presentation by Dr Cooperberg on Wednesday am.

So many other sessions it’s hard to know what to choose from. A mention of Dr Joel Nelson’s Critical Discussion session where he led Dr Reiter and Dr Brooks through the options for patients with progressive prostate cancer. This was a good way to present the key data in an engaging manner.

The AUA Guideline presentations on follow-up care for renal cancer and radiation after prostatectomy were given by Dr. Sherri Donat and Dr. Richard Valicenti, respectively. In addition, Drs. McVary and Kaplan debated the use of alpha blockers versus PDE5 inhibitors for BPH/LUTS.

Other highlights from Tuesday from the land of stones included abstract #1816 – people are 67% less likely to file short-term disability when treated with medical expulsive therapy versus ureteroscopy. A higher physical activity level improves the results of lithotripsy (#1824). In an earlier abstract (#67), physical activity was protected against stones in women. SO…get moving people! Lastly, 2 groups developed nomograms to predict stone-free rates after PCNL (abstracts #1526 and 1532). Thanks to Peter Steinberg and Michelle Semins (my stone peeps) for vetting abstracts.

Social media and twitter continued to have a significant impact at the meeting, with an increasing number of tweets every day. With so much going on at the AUA (seemingly at the same time), twitter provides an easy way for urologists to digitally multitask and get more out of the conference. Check out the metrics via Symplur.com which show huge social media activity (5.7m digital impressions) and also shows the BJUI and its team/contributors are among the top influencers once again.

 

#aua13 was the #1 trending conference over the past few days! The use of social media will only expand over the coming years, and urologists need to stay “ahead of the curve”. Perhaps the @Americanurol will offer a Plenary session on Social Media next year? I can honestly say that I got more out of the meeting this year, largely thanks to the use of twitter.

The AUA responded to a social media campaign and installed twitter-boards around the convention centre. Great to see the AUA engaging so well in social media.

Thanks to the AUA and San Diego for a great meeting! Looking forward to seeing everyone next year in Orlando. Until then, I encourage everyone to participate in the International Journal club on twitter (@iurojc) and to bring a friend!

 

Dr. Matthew Hayn

Follow Matt on Twitter @matthayn

 

Comments on this blog are now closed.

 

Reflections from “The Boards”

Every year in February, 250 or so urologists make the pilgrimage to the Dallas airport to take the Urology Certifying Exam (a.k.a. the Oral Boards). This ranks as one of the strangest events in my life. I felt it appropriate to share my experience.

My trip to Dallas begins with a very sincere “good luck on your test daddy” from my 5-year old daughter. This makes me feel great, until I realize I am less than 24 hours from actually taking the exam. My stress level now starts to rise. As I board the plane in Portland, ME, I see one of my patients. I am pretty sure that I operated on her, but since my brain is crammed full of (now in hindsight) useless information, I cannot remember any details about her. I avoid all eye contact and quickly take my seat. By some miracle, I have the exit row all to myself. Is this a good omen? I feel slightly better until my second flight is delayed on the tarmac for an hour. Nervousness ensues.

I check into the hotel, which is conveniently located at the airport. My room isn’t ready yet, so I wander into the lobby, which is filled with other nervous urologists who are waiting for their rooms. They are all quizzing each other on case scenarios. This doesn’t help my anxiety, so I flee the area. Things become very “real” at registration where all of the other panicky urologists are crammed into a small ballroom. This exam is actually going to happen. I cannot back out now. To make myself feel better, I mock those wearing suits and ties. Who are they trying to impress? I am much cooler than them. Unfortunately, no one passes the boards for being cool. Maybe I should have put on a tie.

It is now t-minus 1 hour to exam time. My brain goes totally blank. I am convinced I have forgotten all of urology. I wonder if my hospital will hire me as a scrub tech. My stress level is now off the charts. I take my first exam – only took 45 minutes. Is this good or bad? I am convinced that I failed, but take solace in the fact that everyone else feels the same way. We are sequestered after the exam for 2 hours. There is nothing else to do, so we all end up talking about the exam. This doesn’t help my anxiety. For the rest of the day, I think about things I should have said during the exam. This again convinces me that I have failed.

As I walk down the long corridor (nicknamed the Green Mile by the staff) to my exam on the second day, all of the examiners are standing in the hallway with half smiles on their faces. What does this mean? Unfortunately, day #2 does not go better than day #1. I now realize why they are all smiling. I am now thoroughly convinced that I have failed. I wonder what I will do when I lose my job. I will need to modify my CV to apply for the scrub tech job. Not sure what else I am qualified to do.

Twenty-four hours later I am slowly relaxing. I try to put things in perspective. The numbers (90% pass rate) tell me that I probably haven’t failed. I am thankful for the colleagues that I saw this past weekend and for new connections that were made. Seeing all of them and sharing this experience confirms why I love urology and can’t see myself doing anything else. We are all blessed to be able to take care of patients and improve their lives. I am looking forward to returning to work tomorrow to get back to being a doctor. And I can’t wait to see my daughter and tell her that daddy did his best.

 

Matthew Hayn is an attending urologist at Maine Medical Center in Portland, ME and an Assistant Clinical Professor of Urology at Tufts University School of Medicine. His views are his own. @matthayn

 

Comments on this blog are now closed.

 

© 2024 BJU International. All Rights Reserved.